Human Oncology & Pathogenesis Program
The Omar Abdel-Wahab Lab
Research

Omar Abdel-Wahab is an Associate Member in Human Oncology and Pathogenesis Program (HOPP) and an Associate Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center. Dr. Abdel-Wahab’s research focuses on the role of genomic alterations in the pathogenesis of hematopoietic malignancies.

Featured News
Publications
People

Omar Abdel-Wahab, MD
Associate Member, Human Oncology and Pathogenesis Program; Associate Attending, Leukemia Service; Director, MSK Center for Hematologic Malignancies
- Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.
- MD, Duke University School of Medicine
- [email protected]
- Email Address
- View physician profile
- Physician profile
Members














Research Scholar

Research Scholar

Research Assistant

Research Technician

Instructor (Pathology)

Research Technician

Research Fellow

Research Associate

Research Associate

Assistant Member, Myeloma Service

Senior Computational Biologist

Program Assistant

Research Technician

Research Scholar







Lab Alumni

Volunteer

Research Fellow

Research Technician

Research Technician
Research Fellow

Administrative Assistant II

Visiting Investigator

Research Technician

Research Fellow

Research Technician

Research Associate

Research Fellow

Senior Research Scientist

Instructor (Dept. of Medicine)

Senior Research Scientist
Lab Affilations
Achievements
- Seldin-Smith Award for Pioneering Research, American Society of Clinical Investigation
- Pershing Square Sohn Prize for Young Investigators in Cancer Research
- Leukemia & Lymphoma Society Clinical Scholar Award
- Joanne Levy Memorial Award for Outstanding Achievement, American Society of Hematology
- V Scholar Award, V Foundation
Read more
- Junior Faculty Scholar Award, American Society of Hematology (ASH)
- Damon Runyon Clinical Investigator Award
Get in Touch
-
Lab Head Email
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Omar Abdel-Wahab discloses the following relationships and financial interests:
-
AIchemy, Inc.
Ownership / Equity Interests; Provision of Services (uncompensated) -
Envisagenics
Ownership / Equity Interests; Provision of Services (uncompensated)
-
Epizyme
Intellectual Property Rights -
Janssen Global Services, LLC
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].